Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R

SIMPLE SUMMARY: The accurate assessment of the aggressiveness and localization of primary prostate cancer lesions are essential for treatment decision making. Around 15% of lesions are missed by PSMA Positron-Emission tomography/computed Tomography (PET/CT). The aim of our study was to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schollhammer, Romain, Quintyn Ranty, Marie-Laure, de Clermont Gallerande, Henri, Cavelier, Florine, Valverde, Ibai E., Vimont, Delphine, Hindié, Elif, Morgat, Clément
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137308/
https://www.ncbi.nlm.nih.gov/pubmed/37190273
http://dx.doi.org/10.3390/cancers15082345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137308/
https://www.ncbi.nlm.nih.gov/pubmed/37190273
http://dx.doi.org/10.3390/cancers15082345

Ejemplares similares